TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Chiesi Pharma AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
870,456
|
738,731
|
638,756 |
| Financial expenses |
604
|
233
|
5,866 |
| Earnings before taxes |
45,578
|
34,312
|
30,827 |
| EBITDA |
51,967
|
39,224
|
42,787 |
| Total assets |
292,881
|
340,876
|
305,420 |
| Current assets |
269,096
|
322,609
|
286,830 |
| Current liabilities |
161,038
|
242,419
|
199,352 |
| Equity capital |
131,843
|
98,457
|
72,703 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
109
|
102
|
98 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
45.0%
|
28.9%
|
23.8% |
| Turnover per employee |
7,986
|
7,242
|
6,518 |
| Profit as a percentage of turnover |
5.2%
|
4.6%
|
4.8% |
| Return on assets (ROA) |
15.8%
|
10.1%
|
12.0% |
| Current ratio |
167.1%
|
133.1%
|
143.9% |
| Return on equity (ROE) |
34.6%
|
34.8%
|
42.4% |
| Change turnover |
131,725
|
99,975
|
131,817 |
| Change turnover % |
18%
|
16%
|
26% |
| Chg. No. of employees |
7
|
4
|
11 |
| Chg. No. of employees % |
7%
|
4%
|
13% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.